See the DrugPatentWatch profile for vyvanse
The cost of Vyvanse without insurance can vary significantly depending on factors such as the dosage, quantity, and the pharmacy where it is purchased. However, without insurance, the retail price for a 30-day supply of Vyvanse can range from approximately $300 to over $500 [1][2].
What is the cash price for Vyvanse?
The cash price for Vyvanse, meaning the cost without any insurance coverage or discount programs, is generally high. For example, a prescription for 30 capsules of 50 mg Vyvanse might cost around $470, while a prescription for 30 capsules of 70 mg could be approximately $490 [1]. These prices reflect the list price set by the manufacturer and can fluctuate between pharmacies and over time.
Are there ways to get Vyvanse cheaper without insurance?
Patients seeking to reduce the cost of Vyvanse without insurance may explore several options. Manufacturer discount cards or coupons can sometimes lower out-of-pocket expenses [2]. Additionally, comparing prices across different pharmacies, including both large chain pharmacies and independent ones, might reveal cost savings. Some patient assistance programs, though often income-dependent, could also offer relief. Examining the cost of alternative stimulant medications, if medically appropriate, might present more affordable treatment pathways.
When does Vyvanse patent expiration occur?
The primary patents for Vyvanse (lisdexamfetamine dimesylate) are expected to expire in the coming years, which could pave the way for generic versions [3]. While specific patent expiry dates can be complex due to multiple patents and potential extensions, many sources indicate that key patents for Vyvanse are set to expire around 2023 and 2025 [4][5]. The actual market entry of generics would depend on regulatory approvals and any ongoing patent litigation.
How does generic Vyvanse pricing compare?
Once generic versions of Vyvanse become available after patent expiration, their prices are typically expected to be considerably lower than the brand-name medication [3]. Generic drugs are often priced at 80-85% less than their brand-name counterparts. The exact pricing of generic lisdexamfetamine dimesylate will depend on the number of manufacturers entering the market and competitive pressures.
What is the difference between brand-name Vyvanse and its generics?
Brand-name Vyvanse and its generic versions contain the same active ingredient, lisdexamfetamine dimesylate, and are required to demonstrate bioequivalence by regulatory agencies like the FDA. This means they should have the same strength, dosage form, route of administration, and intended use. The primary difference typically lies in the inactive ingredients and the cost, with generics being more affordable [3].
Who manufactures Vyvanse and its potential generics?
Vyvanse is manufactured by Takeda Pharmaceuticals. Following patent expiration, other pharmaceutical companies will be eligible to produce and market generic versions of lisdexamfetamine dimesylate, subject to FDA approval [3].
Can I get a Vyvanse prescription filled outside the US for a lower cost?
While it may seem like an option, obtaining prescription medications from outside the U.S. carries significant risks and is generally not recommended due to potential issues with drug safety, efficacy, and legality. Regulations surrounding the import and export of pharmaceuticals are strict, and there is no guarantee that medications obtained this way are legitimate or safe.
Sources:
[1] https://www.goodrx.com/vyvanse
[2] https://www.singlecare.com/prescription/vyvanse
[3] https://drugpatentwatch.com/
[4] https://drugpatentwatch.com/blog/when-will-vyvanse-go-generic/
[5] https://www.valuemd.com/threads/vyvanse-patent-expiring-in-2023.380757/